Target intelligence / Profile preview

N-acetylornithine carbamoyltransferase (AOTC)

Target
AOTC
Molecular classification
Enzyme, Transferase (specifically a carboxy- and carbamoyltransferase; EC 2.1.3.9), Protein
01

Overview

N-acetylornithine carbamoyltransferase (AOTC, EC 2.1.3.9) is an enzyme found in several eubacteria that catalyzes the transfer of a carbamoyl group from carbamoyl phosphate to N(2)-acetyl-L-ornithine, resulting in the formation of N-acetyl-L-citrulline and phosphate[1][2][4][6]. It is part of an alternative arginine biosynthesis pathway that substitutes for ornithine carbamoyltransferase (EC 2.1.3.3) in specific bacterial species and displays no catalytic activity toward L-ornithine[4][7]. The enzyme's activity and unique substrate specificity make it a potential antimicrobial target, especially as it defines a different arginine biosynthetic route compared to canonical pathways in most organisms[3][5][7]. Currently, no well-characterized drugs interact with this target, but inhibitors such as N-acetyl derivatives and related compounds have been used experimentally to study its function and mechanisms[5].

Other names
Acetylornithine transcarbamylaseN-acetylornithine transcarbamylaseAOTCaseCarbamoyl-phosphate:2-N-acetyl-L-ornithine carbamoyltransferase
02

Mechanism of action

Enzyme inhibition (possible mechanism: blocking arginine biosynthesis in microbes by inhibiting AOTC) Substrate competition (in experimental contexts)

03

Biological functions

Arginine biosynthetic pathway (alternative pathway in certain eubacteria)Amino acid binding/catalysisCatalysis of transfer of carbamoyl group from carbamoyl phosphate to N(2)-acetyl-L-ornithine to produce N-acetyl-L-citrulline
04

Disease associations

Other (primarily of microbiological/biochemical relevance, not directly linked to human diseases but may be explored as an antimicrobial drug target)
05

Safety considerations

null
06

Interacting drugs

N-acetyl-L-citrulline (product, no well-characterized therapeutic drug interactions)

1 more in the full profile.

07

Biomarkers

null

Beyond the preview

Go deeper on N-acetylornithine carbamoyltransferase (AOTC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetylornithine carbamoyltransferase (AOTC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call